Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer.

Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer.
复制标题

卵巢癌预后因素及生物标志物研究进展

DOI:
10.7150/jca.47695
复制
发表时间:
2021
期刊:
影响因子:
3.9
通讯作者:
Wang F
Wang F
中科院分区:
医学3区
文献类型:
--
作者:
Liu S;Wu M;Wang F

文献摘要

参考文献

被引文献

相似文献

Ovarian cancer is a serious threat to women's health; its early diagnosis rate is low and prone to metastasis and recurrence. The current conventional treatment for ovarian cancer is a combination of platinum and paclitaxel chemotherapy based on surgery. The recurrence and progression of ovarian cancer with poor prognosis is a major challenge in treatment. With rapid advances in technology, understanding of the molecular pathways involved in ovarian cancer recurrence and progression has increased, biomarker-guided treatment options can greatly improve the prognosis of patients. This review systematically discusses and summarizes existing and new information on prognostic factors and biomarkers of ovarian cancer, which is expected to improve the clinical management of patients and lead to effective personalized treatment.
迁移诱导基因7促进肿瘤发生和血管生成并独立预测上皮性卵巢癌的不良预后
DOI: 10.18632/oncotarget.8487
发表时间: 2016-05-10
期刊: Oncotarget
影响因子: --
作者:
Huang B;Yin M;Li X;Cao G;Qi J;Lou G;Sheng S;Kou J;Chen K;Yu B
通讯作者: Yu B
DOI: 10.1007/s12032-014-0391-z
发表时间: 2015-01
期刊: Medical oncology (Northwood, London, England)
影响因子: --
作者:
Cai Y;Wang J;Zhang L;Wu D;Yu D;Tian X;Liu J;Jiang X;Shen Y;Zhang L;Ren M;Huang P
通讯作者: Huang P
DOI: 10.1038/modpathol.2016.160
发表时间: 2017-02-01
期刊: MODERN PATHOLOGY
影响因子: 7.5
作者:
Ayhan, Ayse;Kuhn, Elisabetta;Wang, Tian-Li
通讯作者: Wang, Tian-Li
DOI: 10.1016/j.ygyno.2006.06.013
发表时间: 2006-09-01
影响因子: 4.7
作者:
Bell, Jeffrey;Brady, Mark F.;Spirtos, Nick M.
通讯作者: Spirtos, Nick M.
DOI: 10.1023/b:glyc.0000014086.38343.98
发表时间: 2002-01-01
影响因子: 3
作者:
Bidon-Wagner, N;Le Pennec, JP
通讯作者: Le Pennec, JP